| Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis AJ Templeton, MG McNamara, B Šeruga, FE Vera-Badillo, P Aneja, ... Journal of the National Cancer Institute 106 (6), dju124, 2014 | 2882 | 2014 |
| Enzalutamide with standard first-line therapy in metastatic prostate cancer ID Davis, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ... New England Journal of Medicine 381 (2), 121-131, 2019 | 1195 | 2019 |
| Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis AJ Templeton, O Ace, MG McNamara, M Al-Mubarak, FE Vera-Badillo, ... Cancer epidemiology, biomarkers & prevention 23 (7), 1204-1212, 2014 | 779 | 2014 |
| Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis FE Vera-Badillo, AJ Templeton, P de Gouveia, I Diaz-Padilla, PL Bedard, ... Journal of the National Cancer Institute 106 (1), djt319, 2014 | 394 | 2014 |
| Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial I Boutron, DG Altman, S Hopewell, F Vera-Badillo, I Tannock, P Ravaud Journal of Clinical Oncology 32 (36), 4120-4126, 2014 | 321 | 2014 |
| HER3 overexpression and survival in solid tumors: a meta-analysis A Ocana, F Vera-Badillo, B Seruga, A Templeton, A Pandiella, E Amir JNCI: Journal of the National Cancer Institute 105 (4), 266-273, 2013 | 235 | 2013 |
| Systemic therapy for non–clear cell renal cell carcinomas: a systematic review and meta-analysis FE Vera-Badillo, AJ Templeton, I Duran, A Ocana, P de Gouveia, P Aneja, ... European urology 67 (4), 740-749, 2015 | 205 | 2015 |
| Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis A Ocana, F Vera-Badillo, M Al-Mubarak, AJ Templeton, ... PloS one 9 (4), e95219, 2014 | 177 | 2014 |
| Simple prognostic score for metastatic castration‐resistant prostate cancer with incorporation of neutrophil‐to‐lymphocyte ratio AJ Templeton, C Pezaro, A Omlin, MG McNamara, R Leibowitz‐Amit, ... Cancer 120 (21), 3346-3352, 2014 | 158 | 2014 |
| Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer FE Vera-Badillo, R Shapiro, A Ocana, E Amir, IF Tannock Annals of Oncology 24 (5), 1238-1244, 2013 | 152 | 2013 |
| Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two … RJ Van Soest, AJ Templeton, FE Vera-Badillo, F Mercier, G Sonpavde, ... Annals of Oncology 26 (4), 743-749, 2015 | 148 | 2015 |
| Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of … AJ Templeton, FE Vera-Badillo, L Wang, M Attalla, P De Gouveia, ... Annals of oncology 24 (12), 2972-2977, 2013 | 148 | 2013 |
| Chromophobe renal cell carcinoma: a review of an uncommon entity FE Vera‐Badillo, E Conde, I Duran International Journal of Urology 19 (10), 894-900, 2012 | 132 | 2012 |
| ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Enzalutamide with standard first-line therapy in metastatic prostate … ID Davis, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ... N Engl J Med 381 (2), 121-131, 2019 | 109 | 2019 |
| Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer R Leibowitz-Amit, AJ Templeton, A Omlin, C Pezaro, EG Atenafu, ... Annals of oncology 25 (3), 657-662, 2014 | 109 | 2014 |
| Niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer KN Chi, D Rathkopf, MR Smith, E Efstathiou, G Attard, D Olmos, JY Lee, ... Journal of Clinical Oncology 41 (18), 3339-3351, 2023 | 103 | 2023 |
| Addition of bevacizumab to chemotherapy for treatment of solid tumors: similar results but different conclusions A Ocaña, E Amir, F Vera, EA Eisenhauer, IF Tannock Journal of Clinical Oncology 29 (3), 254, 2011 | 103 | 2011 |
| Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis GA Gonzalez-Conchas, L Rodriguez-Romo, D Hernandez-Barajas, ... Cancer treatment reviews 62, 1-8, 2018 | 98 | 2018 |
| Prognostic role of Ki-67 score in localized prostate cancer: a systematic review and meta-analysis A Berlin, JF Castro-Mesta, L Rodriguez-Romo, D Hernandez-Barajas, ... Urologic Oncology: Seminars and Original Investigations 35 (8), 499-506, 2017 | 93 | 2017 |
| Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis FE Vera-Badillo, M Napoleone, A Ocana, AJ Templeton, B Seruga, ... Breast cancer research and treatment 146, 235-244, 2014 | 93 | 2014 |
